More intense monitoring makes no difference to outcomes in type 2 diabetes and costs a lot more, but not everyone agrees on what should be done in practice. Carl Heneghan, Ben Goldacre Glucose self-monitoring with automated feedback messaging in type 2 diabetics not taking insulin makes no difference to patient outcomes and costs a lot […]
Is it the end for type 2 diabetes monitoring?
